Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy

Hagemann A, May T, Nieder E, Witte-Boelt K, Pohlmann-Eden B, Elger CE, Tergau F, Schulze-Bonhage A, Straub H-B, Arnold S, Brandt C (2013)
Epilepsy Research 104(1-2): 140-150.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ;
Abstract
The aim of this study was to investigate the change of health related quality of life (HRQoL), anxiety and depression in adult patients in whom an adjunctive treatment with levetiracetam (LEV) was converted to a LEV monotherapy. A prospective, open, investigator initiated multicenter study enrolled 140 patients in whom LEV was added to the existing antiepileptic medication. A total of 65 patients who benefited from the 16-week add-on treatment with LEV (>= 50% seizure reduction) were converted to LEV monotherapy (16-week follow-up). In LEV responders, HRQoL, anxiety and depression improved after add-on of LEV. The subsequent conversion to LEV monotherapy did not lead to a significant change in HRQoL, anxiety and depression. However, comparing baseline with LEV monotherapy, the improvements remained significant for most dimensions of HRQoL and for anxiety and depression. Patients' ratings of efficacy of LEV were related with their HRQoL after the conversion to monotherapy. Add-on therapy of LEV improved HRQoL, anxiety and depression in LEV responders. Conversion to a LEV monotherapy did not inevitably improve HRQoL in LEV responders, but the positive effect was maintained in the majority of the patients. The effects were highly related to seizure reduction. (c) 2012 Elsevier B.V. All rights reserved.
Publishing Year
ISSN
PUB-ID

Cite this

Hagemann A, May T, Nieder E, et al. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Research. 2013;104(1-2):140-150.
Hagemann, A., May, T., Nieder, E., Witte-Boelt, K., Pohlmann-Eden, B., Elger, C. E., Tergau, F., et al. (2013). Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Research, 104(1-2), 140-150.
Hagemann, A., May, T., Nieder, E., Witte-Boelt, K., Pohlmann-Eden, B., Elger, C. E., Tergau, F., Schulze-Bonhage, A., Straub, H. - B., Arnold, S., et al. (2013). Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Research 104, 140-150.
Hagemann, A., et al., 2013. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Research, 104(1-2), p 140-150.
A. Hagemann, et al., “Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy”, Epilepsy Research, vol. 104, 2013, pp. 140-150.
Hagemann, A., May, T., Nieder, E., Witte-Boelt, K., Pohlmann-Eden, B., Elger, C.E., Tergau, F., Schulze-Bonhage, A., Straub, H.-B., Arnold, S., Brandt, C.: Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Research. 104, 140-150 (2013).
Hagemann, Anne, May, Theodor, Nieder, Esther, Witte-Boelt, Karin, Pohlmann-Eden, Bernd, Elger, Christian E., Tergau, Frithjof, Schulze-Bonhage, Andreas, Straub, Hans-Beatus, Arnold, Stephan, and Brandt, Christian. “Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy”. Epilepsy Research 104.1-2 (2013): 140-150.
This data publication is cited in the following publications:
This publication cites the following data publications:

3 Citations in Europe PMC

Data provided by Europe PubMed Central.

Risk factors for postoperative depression: A retrospective analysis of 248 subjects operated on for drug-resistant epilepsy.
Barbieri V, Cardinale F, Gozzo F, Pelliccia V, Nobili L, Casaceli G, Fuschillo D, Castana L, Cossu M, Lo Russo G, Tassi L, Gambini O., Epilepsia 56(10), 2015
PMID: 26299461
The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach.
Magalhaes JC, Gongora M, Vicente R, Bittencourt J, Tanaka G, Velasques B, Teixeira S, Morato G, Basile LF, Arias-Carrion O, Pompeu FA, Cagy M, Ribeiro P., Clin Psychopharmacol Neurosci 13(1), 2015
PMID: 25912541

37 References

Data provided by Europe PubMed Central.

The presence and clinical implications of depression in a community population of adults with epilepsy.
Mensah SA, Beavis JM, Thapar AK, Kerr M., Epilepsy Behav 8(1), 2006
PMID: 16337435
A community study of the presence of anxiety disorder in people with epilepsy.
Mensah SA, Beavis JM, Thapar AK, Kerr MP., Epilepsy Behav 11(1), 2007
PMID: 17532266
The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Morrell MJ, Leppik I, French J, Ferrendelli J, Han J, Magnus L., Epilepsy Res. 54(2-3), 2003
PMID: 12837566
Suicidal ideation in epilepsy and levetiracetam therapy.
Mula M, Sander JW., Epilepsy Behav 11(1), 2007
PMID: 17544331
Psychiatric adverse events during levetiracetam therapy.
Mula M, Trimble MR, Yuen A, Liu RS, Sander JW., Neurology 61(5), 2003
PMID: 12963770
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.
Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J; N166 Levetiracetam Study Group., Neurology 70(8), 2008
PMID: 18285535
A psychosocial view of anxiety and depression in epilepsy.
de Souza EA, Salgado PC., Epilepsy Behav 8(1), 2006
PMID: 16356782
The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I., Epilepsy Res. 76(1), 2007
PMID: 17681453
Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.
Weintraub D, Buchsbaum R, Resor SR Jr, Hirsch LJ., Epilepsy Behav 10(1), 2007
PMID: 17079191
Discontinuation of levetiracetam because of behavioral side effects: a case-control study.
White JR, Walczak TS, Leppik IE, Rarick J, Tran T, Beniak TE, Matchinsky DJ, Gumnit RJ., Neurology 61(9), 2003
PMID: 14610123
Clinically important change in quality of life in epilepsy.
Wiebe S, Matijevic S, Eliasziw M, Derry PA., J. Neurol. Neurosurg. Psychiatr. 73(2), 2002
PMID: 12122166

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 22959715
PubMed | Europe PMC

Search this title in

Google Scholar